ANAB
AnaptysBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$56.80
−1.15%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 40.15x
- P/E 2028E
- 9.99x
- P/S forward
- 44.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 131.93x
- Price / sales
- 7.24x
- Price / cash flow
- 375.56x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 7.20x
- EV / EBITDA
- 28.60x
- EV / EBIT
- 41.00x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026